Previous Close | 0.8500 |
Open | 0.8400 |
Bid | 0.8281 x 100 |
Ask | 0.9148 x 100 |
Day's Range | 0.8300 - 0.8800 |
52 Week Range | 0.6300 - 1.7210 |
Volume | |
Avg. Volume | 179,066 |
Market Cap | 45.788M |
Beta (5Y Monthly) | 1.45 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Lucid Diagnostic's (LUCD) ESOGUARD BE-1 study data shows high sensitivity and negative predictive value for the EsoGuard test, enhancing early detection of esophageal precancer in a screening population.
Discover how Lucid Diagnostics Inc (LUCD) is navigating its financial landscape and strategic initiatives in the first quarter of 2024.